Recognition of a sequestered self peptide by influenza virus-specific CD8+ cytolytic T lymphocytes

Journal of Immunology

Volumn 164, Issue 4, 2000, Pages 1669-1680

  Fan, Rong ^a,b   Tykodi, Scott S ^a,c   Braciale, Thomas J ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLELE; ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL FREE SYSTEM; CELL SURFACE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; IMMUNOLOGICAL TOLERANCE; INFLUENZA VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VIRUS INFECTION;

EID: 0034651906     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.4.1669     Document Type: Article

References (62)

1. Pamer, E., and P. Cresswell. 1998. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16:323.
2. Srivastava, P. K., A. Menoret, S. Basu, R. J. Binder, and K. L. McQuade. 1998. Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. Immunity 8:657.
3. Li, Z., and P. K. Srivastava. 1993. Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation. EMBO J. 12: 3143.
4. Udono, H., and P. K. Srivastava. 1993. Heat shock protein 70-associated peptides elicit specific cancer immunity. J. Exp. Med. 178:1391.
5. Udono, H., and P. K. Srivastava. 1994. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. J. Immunol. 152: 5398.
6. Schild, H., D. Arnold-Schild, E. Lammert, and H.-G. Rammensee. 1999. Stress proteins and immunity mediated by cytotoxic T lymphocytes. Curr. Opin. Immunol. 11:109.
7. Suto, R., and P. K. Srivastava. 1995. A mechanism for the specific immunogenicity of heal shock protein-chaperoned peptides. Science 269:1585.
8. Nieland, T. J. F., M. C. A. A. Tan, M. Monnee-van Muijen, F. Koning, A. M. Kruisbeek, and G. M. van Bleek. 1996. Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94. Proc. Natl. Acad. Sci. USA 93:6135.
9. Breloer, M., T. Marti, B. Fleischer, and A. von Bonin. 1998. Isolation of processed, H-2Kb-binding ovalbumin-derived peptides associated with the stress proteins HSP70 and GP96. Eur. J. Immunol. 28:1016.
10. Jameson, S. C., and M. J. Bevan. 1998. T-cell selection. Curr. Opin. Immunol. 10:214.
11. Tanchot, C., F. A. Lemonnier, B. Pérarnau, A. A. Freitas, and B. Rocha. 1997. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 276:2057.
12. Malnati, M. S., M. Peruzzi, K. C. Parker, W. E. Biddison, E. Ciccone, A. Moretta, and E. O. Long. 1995. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267:1016.
13. Zappacosta, F., F. Borrego, A. G. Brooks, K. C. Parker, and J. E. Coligan. 1997. Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis. Proc. Natl. Acad. Sci. USA 94:6313.
14. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H. G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
15. Ruppert, J., J. Sidney, E. Celis, R. T. Kubo, H. M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929.
16. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. Melief, C. Oseroff, L. Yuan, J. Ruppert, et al. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586.
17. Momburg, F., J. J. Neefjes, and G. J. Hammerling. 1994. Peptide selection by MHC-encoded TAP transporters. Curr. Opin. Immunol. 6:32.
18. Eggers, M., B. Boes-Fabian, T. Ruppert, P. M. Kloetzel, and U. H. Koszinowski. 1995. The cleavage preference of the proteasome governs the yield of antigenic peptides. J. Exp. Med. 182:1865.
19. Niedermann, G., S. Butz, H. G. Ihlenfeldt, R. Grimm, M. Lucchiari, H. Hoschutzky, G. Jung, B. Maier, and K. Eichmann. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 2:289.
20. Sweetser, M. T., V. L. Braciale, and T. J. Braciale. 1988. Class I MHC-restricted recognition of cells expressing a gene encoding a 41 amino acid product of the influenza hemagglutinin. J. Immunol. 141:3324.
21. Braciale, T. J., M. T. Sweetser, L. A. Morrison, D. J. Kittlesen, and V. L. Braciale. 1989. Class I major histocompatibility complex-restricted cylolytic T lymphocytes recognize a limited number of sites on the influenza hemagglutinin. Proc. Natl. Acad. Sci. USA 86:277.
22. Van Pel, A., E. De Plaen, and T. Boon. 1985. Selection of highly transfectable variant from mouse mastocytoma P815. Somatic Cell Mol. Genet. 11:467.
23. Townsend, A., C. Ohlen, J. Bastin, H. G. Ljunggren, L. Foster, and K. Karre. 1989. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340:443.
24. Joseph, L. J., E. Levy, K. Ozato, J. Hochman, and G. M. Shearer. 1986. Differential lack of class I H-2d antigen expression by sublines of the BALB/c S49 T cell lymphoma. J. Immunol. 137:4016.
25. + mouse lymphoma. Immunogenetics 3:75.
26. Braciale, T. J., M. E. Andrew, and V. L. Braciale. 1981. Heterogeneity and specificity of cloned lines of influenza-virus specific cytotoxic T lymphocytes. J. Exp. Med. 153:910.
27. Sugawara, S., T. Abo, and K. Kumagai. 1987. A simple method to eliminate the antigenicity of surface class I MHC molecules from the membrane of viable cells by acid treatment at pH 3. J. Immunol. Methods 100:83.
28. Storkus, W. J., H. J. d. Zeh, R. D. Salter, and M. T. Lotze. 1993. Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. J. Immunother. 14:94.
29. Hunt, D. F., R. A. Henderson, J. Shabanowitz, K. Sakaguchi, H. Michel, N. Sevilir, A. L. Cox, E. Appella, and V. H. Engelhard. 1992. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255:1261.
30. Arnott, D., J. Shabanowitz, and D. F. Hunt. 1993. Mass spectrometry of proteins and peptides: sensitive and accurate mass measurement and sequence analysis. Clin. Chem. 39:2005.
31. Andrew, M. E., B. E. Coupar, G. L. Ada, and D. B. Boyle. 1986. Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants. Microb. Pathog. 1:443.
32. Braciale, T. J., T. J. Henkel, A. Lukacher, and V. L. Braciale. 1986. Fine specificity and antigen receptor expression among influenza virus-specific cytolytic T lymphocyte clones. J. Immunol. 137:995.
33. + T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope. J. Exp. Med. 176:1335.
34. H epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes. J. Exp. Med. 179:195.
35. Milligan, G. N., L. A. Morrison, J. Gorka, V. L. Braciale, and T. J. Braciale. 1990. The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen. J. Immunol. 145:3188.
36. Pamer, E. G., J. T. Harty, and M. J. Bevan. 1991. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature 353:852.
37. Rotzschke, O., K. Falk, S. Stevanovic, G. Jung, P. Walden, and H. G. Rammensee. 1991. Exact prediction of a natural T cell epitope. Eur. J. Immunol. 21:2891.
38. Wallny, H. J., K. Deres, S. Faath, G. Jung, A. Van Pel, T. Boon, and H. G. Rammensee. 1992. Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant. Int. Immunol. 4:1085.
39. Rotzschke, O., K. Falk, K. Deres, H. Schild, M. Norda, J. Metzger, G. Jung, and H. G. Rammensee. 1990. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 348:252.
40. Romero, P., G. Corradin, I. F. Luescher, and J. L. Maryanski. 1991. H-2Kd-restricted antigenic peptides share a simple binding motif. J. Exp. Med. 174:603.
41. Maryanski, J. L., R. Luthy, P. Romero, F. Healy, C. Drouel, J. L. Casanova, C. Jaulin, P. Kourilsky, and G. Corradin. 1993. The interaction of antigenic peptides with the H-2Kd MHC class I molecule. Semin. Immunol. 5:95.
42. Powis, S. J., A. R. Townsend, E. V. Deverson, J. Bastin, G. W. Butcher, and J. C. Howard. 1991. Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter. Nature 354:528.
43. Attaya, M., S. Jameson, C. K. Martinez, E. Hermel, C. Aldrich, J. Forman, K. F. Lindahl, M. J. Bevan, and J. J. Monaco. 1992. Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature 355:647.
44. Yang, Y., K. Fruh, J. Chambers, J. B. Waters, L. Wu, T. Spies, and P. A. Peterson. 1992. Major histocompatibility complex (MHC)-encoded HAM2 is necessary for antigenic peptide loading onto class 1 MHC molecules. J. Biol. Chem. 267:11669.
45. + CTL is more efficient than exogenous presentation. Immunol. Cell Biol. 74:394.
46. Yang, B., and T. J. Braciale. 1995. Characteristics of ATP-dependent peptide transport in isolated microsomes. J. Immunol. 155:3889.
47. Maryanski, J. L., P. Romero, A. Van Pel, T. Boon, F. R. Salemme, J. C. Cerottini, and G. Corradin. 1991. The identification of tyrosine as a common key residue in unrelated H-2Kd restricted antigenic peptides. Int. Immunol. 3:1035.
48. Rotzschke, O., K. Falk, S. Stevanovic, B. Grahovac, M. J. Soloski, G. Jung, and H. G. Rammensee. 1993, Qa-2 molecules are peptide receptors of higher stringency than ordinary class I molecules. Nature 361:642.
49. Joyce, S., P. Tabaczewski, R. H. Angeletti, S. G. Nathenson, and I. Stroynowski. 1994. A nonpolymorphic major histocompatibility complex class Ib molecule binds a large array of diverse self-peptides. J. Exp. Med. 179:579.
50. DeCloux, A., A. S. Woods, R. J. Cotter, M. J. Soloski, and J. Forman. 1997. Dominance of a single peptide bound to the class Ib molecule, Qa-Ib. J. Immunol. 158:2183.
51. Fischer Lindahl, K., D. E. Byers, V. M. Dabhi, R. Hovik, E. P. Jones, G. P. Smith, C.-R. Wang, H. Xiao, and M. Yoshino. 1997. H2-M3, a full-service class Ib histocompatibility antigen. Annu. Rev. Immunol. 15:851.
52. + T cells. Science. 248:1227.
53. + cytolytic T cells. Nature 344:742.
54. Falk, K., O. Rotzschke, and H. G. Rammensee. 1990. Cellular peptide composition governed by major histocompatibility complex class 1 molecules. Nature 348:248.
55. Malarkannan, S., S. Goth, D. R. Buchholz, and N. Shastri. 1995. The role of MHC class I molecules in the generation of endogenous peptide/MHC complexes. J. Immunol. 154:585.
56. Neupert, W. 1997. Protein import into mitochondria. Annu. Rev. Biochem. 66: 863.
57. Mirel, D. B., K. Marder, J. Graziano, G. Freyer, Q. Zhao, R. Mayeux, and K. C. Wilhelmsen. 1998. Characterization of the human mitochondrial aconitase gene (AC02). Gene 213:205.
58. Soltys, B. J., and R. S. Gupta. 1999. Mitochondrial-matrix proteins at unexpected locations: are they exported? Trends Biochem. Sci. 24:174.
59. Gournier, H., S. Pascolo, C. A. Siegrist, J. Jehan, B. Perarnau, Z. Garcia, T. Rose, J. Neefjes, and F. A. Lemonnier. 1995. Restriction of self-antigen presentation to cytolytic T lymphocytes by mouse peptide pumps. Eur. J. Immunol 25:2019.
60. Matsui, M., R. J. Moots, R. J. Warburton, A. L. Peace-Brewer, L. G. Tussey, D. G. Quinn, A. J. McMichael, and J. A. Frelinger. 1995. Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition. J. Immunol. 154:1088.
61. Cyr, D. M., and W. Neupert. 1996. Roles for HSP70 in protein translocation across membranes of organelles. EXS 77:25.
62. Rotzschke, O., K. Falk, S. Faath, and H. G. Rammensee. 1991. On the nature of peptides involved in T cell alloreactivity. J. Exp. Med. 174:1059.